- Home
- TPST vs PDSB Comparison
TPST vs PDSB Comparison
Compare TPST & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- PDSB
- Stock Information
- Founded
- TPST 2011
- PDSB 2005
- Country
- TPST United States
- PDSB United States
- Employees
- TPST N/A
- PDSB N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- TPST Health Care
- PDSB Health Care
- Exchange
- TPST Nasdaq
- PDSB Nasdaq
- Market Cap
- TPST 45.5M
- PDSB 48.0M
- IPO Year
- TPST N/A
- PDSB N/A
- Fundamental
- Price
- TPST $11.02
- PDSB $1.00
- Analyst Decision
- TPST Hold
- PDSB Strong Buy
- Analyst Count
- TPST 3
- PDSB 2
- Target Price
- TPST $30.00
- PDSB $10.00
- AVG Volume (30 Days)
- TPST 45.5K
- PDSB 510.9K
- Earning Date
- TPST 11-11-2025
- PDSB 11-13-2025
- Dividend Yield
- TPST N/A
- PDSB N/A
- EPS Growth
- TPST N/A
- PDSB N/A
- EPS
- TPST N/A
- PDSB N/A
- Revenue
- TPST N/A
- PDSB N/A
- Revenue This Year
- TPST N/A
- PDSB N/A
- Revenue Next Year
- TPST N/A
- PDSB N/A
- P/E Ratio
- TPST N/A
- PDSB N/A
- Revenue Growth
- TPST N/A
- PDSB N/A
- 52 Week Low
- TPST $5.35
- PDSB $0.85
- 52 Week High
- TPST $20.67
- PDSB $3.79
- Technical
- Relative Strength Index (RSI)
- TPST 58.22
- PDSB 31.57
- Support Level
- TPST $8.87
- PDSB $0.94
- Resistance Level
- TPST $11.07
- PDSB $1.05
- Average True Range (ATR)
- TPST 0.47
- PDSB 0.05
- MACD
- TPST 0.07
- PDSB -0.01
- Stochastic Oscillator
- TPST 87.66
- PDSB 14.12
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.